Category: Life Sciences
Global Life Sciences
-
General Surgery Devices
... at a CAGR of 6.0% over the analysis period 2024-2030. Adhesion Prevention Products, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$14.6 Billion by the end ... Read More
-
High Throughput Process Development
... 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Monoclonal Antibodies Molecule, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$17.8 Billion by ... Read More
-
Microelectronic Medical Implants
... at a CAGR of 8.0% over the analysis period 2024-2030. Pacemakers & Defibrillators, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$22.7 Billion by the end ... Read More
-
Aerospace & Life Sciences Testing, Inspection, and Certification
... 2024, is expected to reach US$48.4 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. In-House Testing, Inspection, and Certification, one of the segments analyzed in the report, is expected ... Read More
-
Antibody Production
... CAGR of 10.4% over the analysis period 2024-2030. Monoclonal Antibody Production, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$27.4 Billion by the end of the ... Read More
-
Atomic Force Microscopy
... at a CAGR of 5.9% over the analysis period 2024-2030. Industrial Grade Atomic Force Microscopy, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$695.7 Million by ... Read More
-
Medical Equipment Cooling
... at a CAGR of 4.6% over the analysis period 2024-2030. Liquid Cooling, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$214.4 Million by the end of ... Read More
-
Microtomes
... 6.0% over the analysis period 2024-2030. Microtome Instruments, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$162.8 Million by the end of the analysis period. Growth ... Read More
-
Endoscopy Equipment
... CAGR of 6.2% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$37.5 Billion by the end of the analysis period. ... Read More
-
Exosome Research Products
... at a CAGR of 20.6% over the analysis period 2024-2030. Exosome Research Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by ... Read More
-
Flow Imaging Microscopy/Dynamic Image Analysis
... Million by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Biologics Sample, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$34.7 Million ... Read More
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
... to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like ... Read More
-
Implantable Drug Delivery Devices
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Contraceptive Implants, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$9.8 Billion by the ... Read More
-
Polymerase Chain Reaction Consumables
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. PCR Tubes, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$250.5 Million by the ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Technology Spending on Revenue Cycle Management
... reach US$70.4 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Integrated Platform, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach ... Read More
-
Walnut
... 2.9% over the analysis period 2024-2030. Black Walnuts, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$570.1 Million by the end of the analysis period. Growth ... Read More
-
Transcatheter Heart Valves
... at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the ... Read More
-
Animal Proteins
... CAGR of 6.9% over the analysis period 2024-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$1.6 Billion by the end of ... Read More
-
Polyethylene Glycol Market by Grade, Form (Liquid, White wax, Flake/Powder), Package Size (Drums, Bulk Container, Glass Bottles), End-Use Industry (Pharmaceutical, Cosmetics & Personal care, Food & Beverage, Industrial) & Region - Global Forecast to 2029
... widely used for drug formulations and delivery systems in pharmaceutical industries. It enhances the solubility and bioavailability of poorly soluble drugs. Additionally, due to its low toxicity and non-irritating properties it is widely used in ... Read More
-
Particle Therapy
... CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Patient Monitoring Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Blood Glucose Monitoring Device, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 Billion by the ... Read More
-
Pharmacovigilance
... 9.3% over the analysis period 2024-2030. Contract Outsourcing Service Provider, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$12.3 Billion by the end of the analysis ... Read More
-
Precision Medicine
... CAGR of 8.7% over the analysis period 2024-2030. Diagnostics Application, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$89.0 Billion by the end of the analysis ... Read More
-
Wound Care Biologics
... at a CAGR of 9.8% over the analysis period 2024-2030. Biologic Skin Substitutes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$3.1 Billion by the end ... Read More
Research Assistance
